The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
Hyderabad: Dr Reddy’s Laboratories Ltd., is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride ...
The potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, ...
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
The Board of Kolte Patil Developers at its meeting held on 13 March 2024 has approved the preferential allotment of 1,26,75,685 equity shares (14.3% equity stake) of face value of Rs 10 each at an ...
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 mL), identified as Lot Number A ...
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose infusion bags to the consumer level, in the US.
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double the intended dose of Levetiracetam, leading to severe adverse effects, Dr ...
Dr. Reddys Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results